메뉴 건너뛰기




Volumn 9, Issue 5, 2010, Pages 699-712

QT prolongation in the intensive care unit: Commonly used medications and the impact of drugdrug interactions

Author keywords

Critically ill; Drugdrug interactions; Intensive care units; QT prolongation; Safety; Torsades de pointes

Indexed keywords

ANTIARRHYTHMIC AGENT; ANTIBIOTIC AGENT; ANTIEMETIC AGENT; ANTIHISTAMINIC AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CISAPRIDE; DIURETIC AGENT; DOFETILIDE; DOLASETRON MESILATE; DROPERIDOL; ENFLURANE; FENTANYL; HALOTHANE; HISTAMINE H1 RECEPTOR ANTAGONIST; HYDROXYZINE; IBUTILIDE; ISOFLURANE; MAGNESIUM SULFATE; MORPHINE; NEUROLEPTIC AGENT; ONDANSETRON; PROCAINAMIDE; PROPOFOL; QUINIDINE; SEROTONIN UPTAKE INHIBITOR; SEVOFLURANE; SOTALOL; THIOPENTAL; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG;

EID: 77955947227     PISSN: 14740338     EISSN: None     Source Type: Journal    
DOI: 10.1517/14740331003739188     Document Type: Review
Times cited : (27)

References (178)
  • 1
    • 0033019028 scopus 로고    scopus 로고
    • Drug interactions in the intensive care unit
    • Romac DR, Albertson TE. Drug interactions in the intensive care unit. Clin Chest Med 1999;20(2):385-399
    • (1999) Clin. Chest. Med. , vol.20 , Issue.2 , pp. 385-399
    • Romac, D.R.1    Albertson, T.E.2
  • 2
    • 77953080169 scopus 로고    scopus 로고
    • Significance of drug-drug interactions in cardiac intensive care units
    • Smithburger PL, Kane-Gill SL, Benedict NJ, et al. Significance of drug-drug interactions in cardiac intensive care units. Crit Care Med 2010;37(Suppl 12):A460
    • (2010) Crit. Care. Med. , vol.37 , Issue.12
    • Smithburger, P.L.1    Kane-Gill, S.L.2    Benedict, N.J.3
  • 3
    • 36549059303 scopus 로고    scopus 로고
    • Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome p450 3A4 and the role of therapeutic drug monitoring
    • Zhou SF, Xue CC, Yu XQ, et al. Clinically important drug interactions potentially involving mechanism-based inhibition of cytochrome p450 3A4 and the role of therapeutic drug monitoring. Ther Drug Monit 2007;29(6):687-710
    • (2007) Ther. Drug. Monit. , vol.29 , Issue.6 , pp. 687-710
    • Zhou, S.F.1    Xue, C.C.2    Yu, X.Q.3
  • 4
    • 0033755482 scopus 로고    scopus 로고
    • Drug-drug interactions in medical patients: Effects of in-hospital treatment and relation to multiple drug use
    • Kohler GI, Bode-Boger SM, Busse R, et al. Drug-drug interactions in medical patients: effects of in-hospital treatment and relation to multiple drug use. Int J Clin Pharmacol Ther 2000;38:504-513
    • (2000) Int. J. Clin. Pharmacol. Ther. , vol.38 , pp. 504-513
    • Kohler, G.I.1    Bode-Boger, S.M.2    Busse, R.3
  • 5
    • 0003468905 scopus 로고    scopus 로고
    • Drug interactions analysis and management
    • St. Louis. MO
    • Hansten PD, Horn JR. Drug interactions analysis and management. Facts and comparisons. St. Louis, MO;1999
    • (1999) Facts and Comparisons
    • Hansten, P.D.1    Horn, J.R.2
  • 6
    • 31344470111 scopus 로고    scopus 로고
    • Medication errors and adverse drug events in an intensive care unit: Direct observation approach for detection
    • Kopp BJ, Erstad BL, Allen ME, et al. Medication errors and adverse drug events in an intensive care unit: direct observation approach for detection. Crit Care Med 2006;34:415-425
    • (2006) Crit. Care. Med. , vol.34 , pp. 415-425
    • Kopp, B.J.1    Erstad, B.L.2    Allen, M.E.3
  • 7
    • 0345732111 scopus 로고    scopus 로고
    • Pharmacologic issues in the critically ill
    • Krishnan V, Murray P. Pharmacologic issues in the critically ill. Clin Chest Med 2003;24:671-688
    • (2003) Clin. Chest. Med. , vol.24 , pp. 671-688
    • Krishnan, V.1    Murray, P.2
  • 8
    • 33646148698 scopus 로고    scopus 로고
    • Principles and practices of medication safety in the ICU
    • Kane-Gill SL, Weber RJ. Principles and practices of medication safety in the ICU. Crit Care Clin 2006;22(2):273-290
    • (2006) Crit. Care. Clin. , vol.22 , Issue.2 , pp. 273-290
    • Kane-Gill, S.L.1    Weber, R.J.2
  • 9
    • 34447638865 scopus 로고    scopus 로고
    • Drug disease interactions: Role of inflammatory mediators in disease and variability in drug response
    • Kulmatycki KM, Jamali F. Drug disease interactions: role of inflammatory mediators in disease and variability in drug response. J Pharm Pharm Sci 2005;8:602-625
    • (2005) J. Pharm. Pharm. Sci. , vol.8 , pp. 602-625
    • Kulmatycki, K.M.1    Jamali, F.2
  • 10
    • 2942557103 scopus 로고    scopus 로고
    • Cytochrome P450 regulation and drug biotransformation during inflammation and infection
    • Renton KW. Cytochrome P450 regulation and drug biotransformation during inflammation and infection. Curr Drug Metab 2004;5:235-243
    • (2004) Curr. Drug. Metab. , vol.5 , pp. 235-243
    • Renton, K.W.1
  • 11
    • 44449178386 scopus 로고    scopus 로고
    • Association of antipsychotic and antidepressant drugs with Q-T interval prolongation
    • Zemrak WR, Kenna GA. Association of antipsychotic and antidepressant drugs with Q-T interval prolongation. Am J Health Syst Pharm 2008;65:1029-1038
    • (2008) Am. J. Health. Syst. Pharm. , vol.65 , pp. 1029-1038
    • Zemrak, W.R.1    Kenna, G.A.2
  • 12
    • 1642579574 scopus 로고    scopus 로고
    • A randomized evaluation of six antipsychotic agents on QTc in the absence and presence of metabolic inhibition
    • Harrigan EP, Miceli JJ, Anziano R, et al. A randomized evaluation of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition. J Clin Psychopharmacol 2004;24:62-69
    • (2004) J. Clin. Psychopharmacol , vol.24 , pp. 62-69
    • Harrigan, E.P.1    Miceli, J.J.2    Anziano, R.3
  • 13
    • 5144219993 scopus 로고    scopus 로고
    • Abnormal QT prolongation and psychotropic drug therapy in psychiatric patients: Significance of bradycardia-dependent QT prolongation
    • Sadanaga T, Sadanaga F, Yao H, Fujishima M. Abnormal QT prolongation and psychotropic drug therapy in psychiatric patients: significance of bradycardia-dependent QT prolongation. J Electrocardiol 2004;37(4):267-273
    • (2004) J. Electrocardiol , vol.37 , Issue.4 , pp. 267-273
    • Sadanaga, T.1    Sadanaga, F.2    Yao, H.3    Fujishima, M.4
  • 14
    • 0034022551 scopus 로고    scopus 로고
    • Prolonged QT interval and torsades de pointes caused by the combination of fluconazole and amitriptyline
    • Dorsey ST, Biblo LA. Prolonged QT interval and torsades de pointes caused by the combination of fluconazole and amitriptyline. Am J Emerg Med 2000;18(2):227-229
    • (2000) Am. J. Emerg. Med. , vol.18 , Issue.2 , pp. 227-229
    • Dorsey, S.T.1    Biblo, L.A.2
  • 16
    • 2142660225 scopus 로고    scopus 로고
    • QT prolongation and fatal arrhythmias: a review of clinical implications and effects of drugs
    • Cubeddu LX. QT prolongation and fatal arrhythmias: a review of clinical implications and effects of drugs. Am J Ther 2003;10:452-457
    • (2003) Am. J. Ther. , vol.10 , pp. 452-457
    • Cubeddu, L.X.1
  • 17
    • 57649237613 scopus 로고    scopus 로고
    • Pharmacoepidemiology of QT-interval prolonging drug administration in critically ill patients
    • Freeman BD, Dixon DJ, Coopersmith CM, et al. Pharmacoepidemiology of QT-interval prolonging drug administration in critically ill patients. Pharmacoepidemiol Drug Saf 2008;17:971-981
    • (2008) Pharmacoepidemiol Drug. Saf. , vol.17 , pp. 971-981
    • Freeman, B.D.1    Dixon, D.J.2    Coopersmith, C.M.3
  • 18
    • 0037823364 scopus 로고    scopus 로고
    • Torsades de pointes due to noncardiac drugs most patients have easily identifiable risk factors
    • Zeltser D, Justo D, Halkin A, et al. Torsades de pointes due to noncardiac drugs most patients have easily identifiable risk factors. Medicine 2003;82:282-290
    • (2003) Medicine , vol.82 , pp. 282-290
    • Zeltser, D.1    Justo, D.2    Halkin, A.3
  • 19
    • 16244414305 scopus 로고    scopus 로고
    • Anti-HERG activity and the risk of drug-inducedarrhythmias and sudden death
    • De Bruin ML, Pettersson M, Meyboom RH, et al. Anti-HERG activity and the risk of drug-inducedarrhythmias and sudden death. Eur Heart J 2005;26:590-597
    • (2005) Eur. Heart J. , vol.26 , pp. 590-597
    • De Bruin, M.L.1    Pettersson, M.2    Meyboom, R.H.3
  • 20
    • 26844476445 scopus 로고    scopus 로고
    • Drug-induced Q-T prolongation
    • Kao LW, Furbee RB. Drug-induced Q-T prolongation. Med Clin N Am 2005;89:1125-1144
    • (2005) Med. Clin. N. Am. , vol.89 , pp. 1125-1144
    • Kao, L.W.1    Furbee, R.B.2
  • 21
    • 0036847942 scopus 로고    scopus 로고
    • Duke Clinical Research Institute/American Heart Journal expert meeting on repolarization C. Cardiac repolarization: Current knowledge critical gaps and new approaches to drug development and patient management
    • Anderson ME, Al-Khatib SM, Roden DM, Califf RM. Duke Clinical Research Institute/American Heart Journal expert meeting on repolarization C. Cardiac repolarization: current knowledge, critical gaps, and new approaches to drug development and patient management. Am Heart J 2002;144(5):769-781
    • (2002) Am. Heart. J. , vol.144 , Issue.5 , pp. 769-781
    • Anderson, M.E.1    Al-Khatib, S.M.2    Roden, D.M.3    Califf, R.M.4
  • 22
    • 0242494266 scopus 로고    scopus 로고
    • What clinicians should know about the QT interval
    • Al-Khatib SM, LaPointe NM, Kramer JM, et al. What clinicians should know about the QT interval. JAMA 2003;289(16):2120-2127
    • (2003) JAMA , vol.289 , Issue.16 , pp. 2120-2127
    • Al-Khatib, S.M.1    LaPointe, N.M.2    Kramer, J.M.3
  • 23
    • 0035985144 scopus 로고    scopus 로고
    • Drug induced prolongation of the QT interval: Regulatory dilemmas and implications for approval and labeling of a new chemical entity
    • Shah RR. Drug induced prolongation of the QT interval: regulatory dilemmas and implications for approval and labeling of a new chemical entity. Fundam Clin Pharmacol 2002;16:147-156
    • (2002) Fundam. Clin. Pharmacol. , vol.16 , pp. 147-156
    • Shah, R.R.1
  • 24
    • 1442306232 scopus 로고    scopus 로고
    • Drug-induced prolongation of the QT interval
    • Roden DM. Drug-induced prolongation of the QT interval. N Engl J Med 2004;350(10):1013-1022
    • (2004) N. Engl. J. Med. , vol.350 , Issue.10 , pp. 1013-1022
    • Roden, D.M.1
  • 25
    • 0037705711 scopus 로고    scopus 로고
    • Clinical relevance and management of drug-related QT interval prolongation
    • Crouch MA, Limon L, Cassano AT. Clinical relevance and management of drug-related QT interval prolongation. Pharmacotherapy 2003;23(7):881-908
    • (2003) Pharmacotherapy , vol.23 , Issue.7 , pp. 881-908
    • Crouch, M.A.1    Limon, L.2    Cassano, A.T.3
  • 26
    • 0036322892 scopus 로고    scopus 로고
    • Antipsychotic-related QTc prolongation torsade de pointes and sudden death
    • Haddad PM, Anderson IM. Antipsychotic-related QTc prolongation, torsade de pointes and sudden death. Drugs 2002;62(11):1649-1671
    • (2002) Drugs , vol.62 , Issue.11 , pp. 1649-1671
    • Haddad, P.M.1    Anderson, I.M.2
  • 27
    • 0035021986 scopus 로고    scopus 로고
    • Evaluation of drug-induced QT interval prolongation: Implications for drug approval and labeling
    • Malik M, Camm AJ. Evaluation of drug-induced QT interval prolongation: implications for drug approval and labeling. Drug Saf 2001; 24:323-351
    • (2001) Drug Saf. , vol.24 , pp. 323-351
    • Malik, M.1    Camm, A.J.2
  • 28
    • 0036181222 scopus 로고    scopus 로고
    • Relation between QT and RR intervals ishighly individual among healthy subjects: Implications for heart rate correction fot eh QT interval
    • Malik M, Farbom P, Batchvarov V, et al. Relation between QT and RR intervals ishighly individual among healthy subjects: implications for heart rate correction fot eh QT interval. Heart 2002;87:220-228
    • (2002) Heart , vol.87 , pp. 220-228
    • Malik, M.1    Farbom, P.2    Batchvarov, V.3
  • 29
    • 0036086224 scopus 로고    scopus 로고
    • QT-RR relationship in healthy subjects exhibits substantial intersubject variability and high intrasubject stability
    • Batchvarov VN, Ghuran A, Smetana P, et al. QT-RR relationship in healthy subjects exhibits substantial intersubject variability and high intrasubject stability. Am J Physiol Heart Circ Physiol 2002;282:H2356-63
    • (2002) Am. J. Physiol. Heart Circ. Physiol. , vol.282
    • Batchvarov, V.N.1    Ghuran, A.2    Smetana, P.3
  • 30
    • 35148890709 scopus 로고    scopus 로고
    • Drug-induced QT prolongation and torsades de pointes: Evaluation of a QT nomogram
    • Chan A, Isbister GK, Kirkpatrick CMJ, Dufful SB. Drug-induced QT prolongation and torsades de pointes: evaluation of a QT nomogram. Q J Med 2007;100:609-615
    • (2007) Q. J. Med. , vol.100 , pp. 609-615
    • Chan, A.1    Isbister, G.K.2    Kirkpatrick, C.M.J.3    Dufful, S.B.4
  • 31
    • 70350482293 scopus 로고    scopus 로고
    • Inter-rate reliability of manual QT measurement and prediction of abnormal QT HR pairs
    • Isbister GK, Calver L, Gorp FV, et al. Inter-rate reliability of manual QT measurement and prediction of abnormal QT, HR pairs. Clin Toxicol 2009;27:884-888
    • (2009) Clin. Toxicol. , vol.27 , pp. 884-888
    • Isbister, G.K.1    Calver, L.2    Gorp, F.V.3
  • 32
    • 11844276000 scopus 로고    scopus 로고
    • Dynamic beat-to-beat modeling of the QT-RR interval relationship: Analysis of QT prolongation during alterations of autonomic state versus human ether a-go-go-related gene inhibition
    • Fossa AA, Wisialowski T, Magnano A, et al. Dynamic beat-to-beat modeling of the QT-RR interval relationship: analysis of QT prolongation during alterations of autonomic state versus human ether a-go-go-related gene inhibition. J Pharmacol Exp Ther 2005;312:1-11
    • (2005) J. Pharmacol. Exp. Ther. , vol.312 , pp. 1-11
    • Fossa, A.A.1    Wisialowski, T.2    Magnano, A.3
  • 33
    • 0028115856 scopus 로고
    • Torsade de pointes Mechanisms and management
    • Napolitano C, Priori SG, Schwartz PJ. Torsade de pointes. Mechanisms and management. Drugs 1994;47:51-65
    • (1994) Drugs , vol.47 , pp. 51-65
    • Napolitano, C.1    Priori, S.G.2    Schwartz, P.J.3
  • 34
    • 0034917323 scopus 로고    scopus 로고
    • Organising evidence on QT prolongation and occurrence of torsades de pointes with non-antiarrhythmic drugs: A call for consensus
    • De Ponti F, Poluzzi E, Montanaro N. Organising evidence on QT prolongation and occurrence of torsades de pointes with non-antiarrhythmic drugs: a call for consensus. Eur J Clin Pharmacol 2001;57(3):185-209
    • (2001) Eur J Clin Pharmacol. , vol.57 , Issue.3 , pp. 185-209
    • De Ponti, F.1    Poluzzi, E.2    Montanaro, N.3
  • 35
    • 0142209158 scopus 로고    scopus 로고
    • Drug induced QT prolongation and torsades de pointes
    • Yap YG, Camm AJ. Drug induced QT prolongation and torsades de pointes. Heart 2003;89(11):1363-1372
    • (2003) Heart , vol.89 , Issue.11 , pp. 1363-1372
    • Yap, Y.G.1    Camm, A.J.2
  • 36
    • 0034609531 scopus 로고    scopus 로고
    • Spectrum of mutations in long-QT syndrome genes kvlqt1 herg scn5a kcne1 and kcne2
    • Splawski I, Shen J, Timothy KW, et al. Spectrum of mutations in long-QT syndrome genes. KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation 2000;102(10):1178-1185
    • (2000) Circulation , vol.102 , Issue.10 , pp. 1178-1185
    • Splawski, I.1    Shen, J.2    Timothy, K.W.3
  • 38
    • 33845772917 scopus 로고    scopus 로고
    • Torsade de Pointes
    • Zipes DP, Jalite J, editors 4th edition. WB Saunders, Philadelphia;
    • El-Sherif N, Turottio G. Torsade de Pointes. In: Zipes DP, Jalite J, editors, Cardiac electrophysiology, from cell to bedside. 4th edition. WB Saunders, Philadelphia; 2004. p. 689-699
    • (2004) Cardiac Electrophysiology from Cell to Bedside , pp. 689-699
    • El-Sherif, N.1    Turottio, G.2
  • 39
    • 0032970148 scopus 로고    scopus 로고
    • Dysfunction of delayed rectifier potassium channels in an inherited cardiac arrhythmia
    • Sanguinetti MC. Dysfunction of delayed rectifier potassium channels in an inherited cardiac arrhythmia. Ann NY Acad Sci 1999;868:406-413
    • (1999) Ann. NY. Acad. Sci. , vol.868 , pp. 406-413
    • Sanguinetti, M.C.1
  • 41
    • 84901472568 scopus 로고    scopus 로고
    • Sudden Arrhythmia Death Syndromes Foundation. SADS Foundation. Available from:
    • Sudden Arrhythmia Death Syndromes Foundation. The long QT syndrome. SADS Foundation. Available from: www.sads.org
    • The Long QT Syndrome
  • 42
    • 58149231337 scopus 로고    scopus 로고
    • Hydroxyzine a first generation H1-receptor antagonist inhibits human ether-a-go-go-related gene HERGcurrent and causes syncope in a patient with the herg mutation
    • Sakaguchi T Itoh H, Ding WG, et al. Hydroxyzine, a first generation H1-receptor antagonist, inhibits human ether-a-go-go-related gene (HERG) current and causes syncope in a patient with the herg mutation. J Pharmacol Sci 2008;108(4):462-471
    • (2008) J. Pharmacol. Sci. , vol.108 , Issue.4 , pp. 462-471
    • Sakaguchi, T.1    Itoh, H.2    Ding, W.G.3
  • 43
    • 0036258115 scopus 로고    scopus 로고
    • Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: an overview
    • De Pointi F, Poluzzi E, Cavalli A, et al. Safety of non-antiarrhythmic drugs that prolong the QT interval or induce torsade de pointes: an overview. Drug Saf 2002;25(4)263-286
    • (2002) Drug. Saf. , vol.25 , Issue.4 , pp. 263-286
    • De Pointi, F.1    Poluzzi, E.2    Cavalli, A.3
  • 44
    • 2942560844 scopus 로고    scopus 로고
    • QT prolongation with antimicrobial agents: Understanding the significance
    • Owens RC Jr. QT prolongation with antimicrobial agents: understanding the significance. Drugs 2004;64(10):1091-1124
    • (2004) Drugs , vol.64 , Issue.10 , pp. 1091-1124
    • Owens, Jr.R.C.1
  • 45
    • 23944505508 scopus 로고    scopus 로고
    • Risk factors for prolonged QTc among US adults: Third national health and nutrition examination survey
    • Benoit SR, Mendelsohn AB, Nourjah P, et al. Risk factors for prolonged QTc among US adults: third national health and nutrition examination survey. Eur J Cardiovasc Prev Rehabil 2005;12:363-368
    • (2005) Eur. J. Cardiovasc. Prev. Rehabil. , vol.12 , pp. 363-368
    • Benoit, S.R.1    Mendelsohn, A.B.2    Nourjah, P.3
  • 46
    • 0242293858 scopus 로고    scopus 로고
    • Sympathovagal balance, nighttime blood pressure and QT intervals in normotensive obese women
    • Esposito K, Marfella R, Gualdiero P, et al. Sympathovagal balance, nighttime blood pressure, and QT intervals in normotensive obese women. Obes Res 2003;11:653-659
    • (2003) Obes. Res. , vol.11 , pp. 653-659
    • Esposito, K.1    Marfella, R.2    Gualdiero, P.3
  • 47
    • 0346887077 scopus 로고    scopus 로고
    • Effects of weight loss on QT interval in morbidly obese patients
    • Papaioannou A, Michaloudis D, Fraidakis O, et al. Effects of weight loss on QT interval in morbidly obese patients. Obes Surg 2003;13:869-873
    • (2003) Obes. Surg. , vol.13 , pp. 869-873
    • Papaioannou, A.1    Michaloudis, D.2    Fraidakis, O.3
  • 48
    • 0022625266 scopus 로고
    • The electrocardiogram in obesity: Statistical analysis of 1 029 patients
    • Frank S, Colliver JA, Frank A. The electrocardiogram in obesity: statistical analysis of 1,029 patients. J Am Coll Cardiol 1986;7:295-299
    • (1986) J. Am. Coll. Cardiol. , vol.7 , pp. 295-299
    • Frank, S.1    Colliver, J.A.2    Frank, A.3
  • 49
    • 0034878513 scopus 로고    scopus 로고
    • Impaired fasting glucose, diabetes mellitus and cardiovascular disease risk factors are associated with prolonged QT duration. Results from the third national health and nutrition examination survey
    • Brown DW, Giles WH, Greenlund KJ, et al. Impaired fasting glucose, diabetes mellitus, and cardiovascular disease risk factors are associated with prolonged QT duration. Results from the third national health and nutrition examination survey. J Cardiovasc Risk 2001;8:227-233
    • (2001) J. Cardiovasc. Risk. , vol.8 , pp. 227-233
    • Brown, D.W.1    Giles, W.H.2    Greenlund, K.J.3
  • 50
    • 0028968773 scopus 로고
    • Effects of obesity on QT RR and QTc intervals
    • El-Gamal A, Gallagher D, Nawras A, et al. Effects of obesity on QT, RR and QTc intervals. Am J Cardiol 1995;75:956-959
    • (1995) Am J Cardiol , vol.75 , pp. 956-959
    • El-Gamal, A.1    Gallagher, D.2    Nawras, A.3
  • 51
    • 0036363739 scopus 로고    scopus 로고
    • Electrocardiographic changes in patients with acute stroke: A systematic review
    • Khechinashvili G, Asplund K. Electrocardiographic changes in patients with acute stroke: a systematic review. Cerebrovasc Dis 2002;14:67-76
    • (2002) Cerebrovasc. Dis. , vol.14 , pp. 67-76
    • Khechinashvili, G.1    Asplund, K.2
  • 52
    • 0031916794 scopus 로고    scopus 로고
    • The long QT syndrome: Ion channel diseases of the heart
    • Ackerman MJ. The long QT syndrome: ion channel diseases of the heart. Mayo Clin Proc 1998;73:175-187
    • (1998) Mayo. Clin. Proc. , vol.73 , pp. 175-187
    • Ackerman, M.J.1
  • 53
    • 17144415220 scopus 로고    scopus 로고
    • Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing
    • Tester DJ, Will ML, Haglund CM, Ackerman MJ. Compendium of cardiac channel mutations in 541 consecutive unrelated patients referred for long QT syndrome genetic testing. Heart Rhythm 2005;2:507-517
    • (2005) Heart. Rhythm. , vol.2 , pp. 507-517
    • Tester, D.J.1    Will, M.L.2    Haglund, C.M.3    Ackerman, M.J.4
  • 54
    • 29144494740 scopus 로고    scopus 로고
    • Genetic testing in the long QT syndrome: Development and validation of an efficient approach to genotyping in clinical practice
    • Napolitano C, Priori SG, Schwartz PJ, et al. Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice. JAMA 2005;294:2975-2980
    • (2005) JAMA , vol.294 , pp. 2975-2980
    • Napolitano, C.1    Priori, S.G.2    Schwartz, P.J.3
  • 55
    • 0034609531 scopus 로고    scopus 로고
    • Spectrum of mutations in long-QT syndrome genes: Kvlqt1 herg scn5a kcne1 and KCNE2
    • Splawski I, Shen J, Timothy KW, et al. Spectrum of mutations in long-QT syndrome genes: KVLQT1, HERG, SCN5A, KCNE1, and KCNE2. Circulation 2000;102:1178-1185
    • (2000) Circulation , vol.102 , pp. 1178-1185
    • Splawski, I.1    Shen, J.2    Timothy, K.W.3
  • 56
    • 34447307435 scopus 로고    scopus 로고
    • SCN4B-encoded sodium channel beta4 subunit in congenital long-QT syndrome
    • Medeiros-Domingo A, Kaku T, Tester DJ, et al. SCN4B-encoded sodium channel beta4 subunit in congenital long-QT syndrome. Circulation 2007;116:134-142
    • (2007) Circulation , vol.116 , pp. 134-142
    • Medeiros-Domingo, A.1    Kaku, T.2    Tester, D.J.3
  • 57
    • 0037161355 scopus 로고    scopus 로고
    • Allelic variants in long-QT disease in patients with drug-associated torsades de pointes
    • Yang P, Kanki H, Drolet B, et al. Allelic variants in long-QT disease in patients with drug-associated torsades de pointes. Circulation 2002;105:1943-1948
    • (2002) Circulation , vol.105 , pp. 1943-1948
    • Yang, P.1    Kanki, H.2    Drolet, B.3
  • 58
    • 0023007223 scopus 로고
    • Amiodarone and hypokalemia. A dangerous combination
    • Moro C, Romero J, Peiretti MAC. Amiodarone and hypokalemia. A dangerous combination. Intl J Cardiol 1986;13:365-368
    • (1986) Intl. J. Cardiol. , vol.13 , pp. 365-368
    • Moro, C.1    Romero, J.2    Peiretti, M.A.C.3
  • 59
    • 0020702387 scopus 로고
    • Amiodarone-induced polymorphous ventricular tachycardia
    • Sclarovsky S, Lewin RF, Kracoff O, et al. Amiodarone-induced polymorphous ventricular tachycardia. Am Heart J 1983;105:6-12
    • (1983) Am. Heart. J. , vol.105 , pp. 6-12
    • Sclarovsky, S.1    Lewin, R.F.2    Kracoff, O.3
  • 60
    • 0031886442 scopus 로고    scopus 로고
    • Adverse effects of amiodarone
    • Pt I
    • Jafari-Fesharaki M, Scheinman MM. Adverse effects of amiodarone. PACE 1998;21(Pt I):108-120
    • (1998) PACE , vol.21 , pp. 108-120
    • Jafari-Fesharaki, M.1    Scheinman, M.M.2
  • 61
    • 0022615210 scopus 로고
    • Asystole following a conventional therapeutic dose of lidocaine
    • Appelbaum D, Halperin E. Asystole following a conventional therapeutic dose of lidocaine. Am J Emerg Med 1986;4:143-145
    • (1986) Am. J. Emerg. Med. , vol.4 , pp. 143-145
    • Appelbaum, D.1    Halperin, E.2
  • 62
    • 0018187998 scopus 로고
    • Lidocaine-induced cardiac asystole
    • Manyari-Ortega DE, Brennan FJ. Lidocaine-induced cardiac asystole. Chest 1978;74:227-229
    • (1978) Chest , vol.74 , pp. 227-229
    • Manyari-Ortega, D.E.1    Brennan, F.J.2
  • 63
    • 0030818877 scopus 로고    scopus 로고
    • Torsades de pointes with administration of high-dose intravenous d-sotalol to a patient with congestive heart failure
    • Gottlieb SS, Cines M, Marshall J. Torsades de pointes with administration of high-dose intravenous d-sotalol to a patient with congestive heart failure. Pharmacotherapy 1997;17:830-831
    • (1997) Pharmacotherapy , vol.17 , pp. 830-831
    • Gottlieb, S.S.1    Cines, M.2    Marshall, J.3
  • 64
    • 0030743943 scopus 로고    scopus 로고
    • Torsade de pointes and prolonged QT interval from surreptitious use of sotalol: Use of drug levels in diagnosis
    • Link MS, Foote CB, Sloan SB, et al. Torsade de pointes and prolonged QT interval from surreptitious use of sotalol: use of drug levels in diagnosis. Chest 1997;112:556-557
    • (1997) Chest , vol.112 , pp. 556-557
    • Link, M.S.1    Foote, C.B.2    Sloan, S.B.3
  • 65
    • 0034321598 scopus 로고    scopus 로고
    • Visual diagnosis in emergency medicine. Hypokalemia-induced QT interval prolongation
    • Marinella MA, Burdette SD. Visual diagnosis in emergency medicine. Hypokalemia-induced QT interval prolongation. J Emerg Med 2000;19(4):375-376
    • (2000) J. Emerg. Med. , vol.19 , Issue.4 , pp. 375-376
    • Marinella, M.A.1    Burdette, S.D.2
  • 66
    • 0029560204 scopus 로고
    • Diuretic-induced hypokalemia inducing torsades de pointes
    • Chvilicek JP, Hurlbert BJ, Hill GE. Diuretic-induced hypokalemia inducing torsades de pointes. Can J Anaesth 1995;42(12):1137-1139
    • (1995) Can. J. Anaesth. , vol.42 , Issue.12 , pp. 1137-1139
    • Chvilicek, J.P.1    Hurlbert, B.J.2    Hill, G.E.3
  • 67
    • 0036750057 scopus 로고    scopus 로고
    • Serious ventricular arrhythmias among users of cisapride and other QT-prolonging agents in the United States
    • Enger C, Cali C, Walker AM. Serious ventricular arrhythmias among users of cisapride and other QT-prolonging agents in the United States. Pharmacoepidmiol Drug Saf 2002;11:477-486
    • (2002) Pharmacoepidmiol Drug. Saf. , vol.11 , pp. 477-486
    • Enger, C.1    Cali, C.2    Walker, A.M.3
  • 68
    • 0027474601 scopus 로고
    • Mechanism of the cardiotoxic actions of terfenadine
    • Woosley RL, Chen Y, Freiman JP, Gillis RA. Mechanism of the cardiotoxic actions of terfenadine. JAMA 1993;269:1532-1536
    • (1993) JAMA , vol.269 , pp. 1532-1536
    • Woosley, R.L.1    Chen, Y.2    Freiman, J.P.3    Gillis, R.A.4
  • 69
    • 0034967764 scopus 로고    scopus 로고
    • Postmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and food and drug administration regulatory actions
    • Wysowski DK, Corken A, Gallo-Torres H, et al. Postmarketing reports of QT prolongation and ventricular arrhythmia in association with cisapride and food and drug administration regulatory actions. Am J Gastroenterol 2001;96:1698-1703
    • (2001) Am. J. Gastroenterol , vol.96 , pp. 1698-1703
    • Wysowski, D.K.1    Corken, A.2    Gallo-Torres, H.3
  • 70
    • 0027468346 scopus 로고
    • Terfenadine-ketoconazole interactions
    • Honig PK, Wortham DC, Zamani K, et al. Terfenadine-ketoconazole interactions. JAMA 1993;269:1513-1518
    • (1993) JAMA , vol.269 , pp. 1513-1518
    • Honig, P.K.1    Wortham, D.C.2    Zamani, K.3
  • 72
    • 19744377392 scopus 로고    scopus 로고
    • Prolongation of QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansetron
    • Charbit B, Albaladejo P, Funck-Bretano C, et al. Prolongation of QTc interval after postoperative nausea and vomiting treatment by droperidol or ondansetron. Anesthesiology 2005;102:1094-1100
    • (2005) Anesthesiology , vol.102 , pp. 1094-1100
    • Charbit, B.1    Albaladejo, P.2    Funck-Bretano, C.3
  • 73
    • 48849117034 scopus 로고    scopus 로고
    • Droperidol and ondansetron-induced QT interval prolongation
    • Charbit B, Alvarez JC, Dasque E, et al. Droperidol and ondansetron-induced QT interval prolongation. Anesthesiology 2008;109:206-212
    • (2008) Anesthesiology , vol.109 , pp. 206-212
    • Charbit, B.1    Alvarez, J.C.2    Dasque, E.3
  • 74
    • 0034967764 scopus 로고    scopus 로고
    • Postmarketing reports if QT prolongation with ventricular arrhythmia in association with cisapride and food and drug administration regulatory actions
    • Wysowski DK, Corken A, Gallo-Torres H, et al. Postmarketing reports if QT prolongation with ventricular arrhythmia in association with cisapride and food and drug administration regulatory actions. Am J Gastroenterol 2001;96:1698-1703
    • (2001) Am. J. Gastroenterol , vol.96 , pp. 1698-1703
    • Wysowski, D.K.1    Corken, A.2    Gallo-Torres, H.3
  • 76
    • 0037407990 scopus 로고    scopus 로고
    • Food and drug administration black box warning on the perioperative use of droperidol: A review of the cases
    • Habib AS, Gan TJ. Food and drug administration black box warning on the perioperative use of droperidol: a review of the cases. Anesth Analg 2003;96:1377-1379
    • (2003) Anesth. Analg. , vol.96 , pp. 1377-1379
    • Habib, A.S.1    Gan, T.J.2
  • 78
    • 11444256447 scopus 로고    scopus 로고
    • Anesthesia for patients with congenital long QT syndrome
    • Kies SJ, Pabelick CM, Hurley HA, et al. Anesthesia for patients with congenital long QT syndrome. Anesthesiology 2005;102:204-210
    • (2005) Anesthesiology , vol.102 , pp. 204-210
    • Kies, S.J.1    Pabelick, C.M.2    Hurley, H.A.3
  • 80
    • 0033758622 scopus 로고    scopus 로고
    • Sevoflurane progressively prolongs the QT interval in unpremedicated female adults
    • Kuenszberg E, Loeckinger A, Kleinsasser A, et al. Sevoflurane progressively prolongs the QT interval in unpremedicated female adults. Eur J Anaesthesiol 2000;17:662-664
    • (2000) Eur. J. Anaesthesiol , vol.17 , pp. 662-664
    • Kuenszberg, E.1    Loeckinger, A.2    Kleinsasser, A.3
  • 81
    • 0025872679 scopus 로고
    • Prolongation of the QT interval by enflurane, isoflurane and alothane in humans
    • Schmeling WT, Warltier DC, McDonald DJ, et al. Prolongation of the QT interval by enflurane, isoflurane, and alothane in humans. Anesth Analg 1991;72:137-144
    • (1991) Anesth Analg , vol.72 , pp. 137-144
    • Schmeling, W.T.1    Warltier, D.C.2    McDonald, D.J.3
  • 83
    • 0020558214 scopus 로고
    • Prolongation of QT interval during induction of anaesthesia
    • Saarnivaara L, Lindgren L. Prolongation of QT interval during induction of anaesthesia. Acta Anaesth Scand 1982;27:126-130
    • (1982) Acta. Anaesth. Scand. , vol.27 , pp. 126-130
    • Saarnivaara, L.1    Lindgren, L.2
  • 84
    • 0033957440 scopus 로고    scopus 로고
    • Sevoflurance but not propofol significantly prolongs the QT interval
    • Kleinsasser A, Keunszberg E, Loeckinger A, et al. Sevoflurance, but not propofol, significantly prolongs the QT interval. Anesth Analg 2000;90:25-27
    • (2000) Anesth. Analg. , vol.90 , pp. 25-27
    • Kleinsasser, A.1    Keunszberg, E.2    Loeckinger, A.3
  • 85
    • 0035095346 scopus 로고    scopus 로고
    • Reversing sevoflurane-associated QTc prolongation by changing to propofol
    • Kleinsasser A, Loeckinger A, Linder KH, et al. Reversing sevoflurane-associated QTc prolongation by changing to propofol. Anaesthesia 2001;56:248-250
    • (2001) Anaesthesia , vol.56 , pp. 248-250
    • Kleinsasser, A.1    Loeckinger, A.2    Linder, K.H.3
  • 86
    • 0028786547 scopus 로고
    • The effects of midazolam followed by administration of either vecuronium or atracurium on the QT interval in humans
    • Michaloudis DG, Kanakoudis FS, Xatzikraniotis A, Bischinotis TS. The effects of midazolam followed by administration of either vecuronium or atracurium on the QT interval in humans. Eur J Anaesthesiol 1995;12:577-583
    • (1995) Eur. J. Anaesthesiol , vol.12 , pp. 577-583
    • Michaloudis, D.G.1    Kanakoudis, F.S.2    Xatzikraniotis, A.3    Bischinotis, T.S.4
  • 87
    • 0028158568 scopus 로고
    • Prolongation of the QT interval during induction of anesthesia in patients with coronary artery disease
    • Lischke V, Wilke HJ, Probst S, et al. Prolongation of the QT interval during induction of anesthesia in patients with coronary artery disease. Acta Anaesthesiol Scand 1994;38:144-148
    • (1994) Acta. Anaesthesiol Scand. , vol.38 , pp. 144-148
    • Lischke, V.1    Wilke, H.J.2    Probst, S.3
  • 88
    • 0017656650 scopus 로고
    • Anesthetic management of prolonged QT interval syndrome
    • Callahan ML, Nichols AB, Sweet RB. Anesthetic management of prolonged QT interval syndrome. Anesthesiology 1977;47:67-69
    • (1977) Anesthesiology , vol.47 , pp. 67-69
    • Callahan, M.L.1    Nichols, A.B.2    Sweet, R.B.3
  • 89
    • 0024917731 scopus 로고
    • Torsades de pointe during an atropine sulfate test in a patient with congenital long QT syndrome
    • Beccaria E, Brun S, Gaita F, et al. Torsades de pointe during an atropine sulfate test in a patient with congenital long QT syndrome. Cardiologia 1989;34:1039-1043
    • (1989) Cardiologia. , vol.34 , pp. 1039-1043
    • Beccaria, E.1    Brun, S.2    Gaita, F.3
  • 90
    • 0031909021 scopus 로고    scopus 로고
    • Effects of four anticholinesterase-anticholinergic combinations and tracheal extubation on QTc interval of the ECK heart rate and arterial pressure
    • Saarnivaara L, Simoa M. Effects of four anticholinesterase- anticholinergic combinations and tracheal extubation on QTc interval of the ECK, heart rate and arterial pressure. Acta Anesthesiol Scand 1998;42:460-463
    • (1998) Acta. Anesthesiol. Scand. , vol.42 , pp. 460-463
    • Saarnivaara, L.1    Simoa, M.2
  • 91
    • 0020535192 scopus 로고
    • Benumof jl. Perioperatve management of the prolonged QT interval syndrome
    • Medak R, Benumof jl. Perioperatve management of the prolonged QT interval syndrome. Br J Anaesth 1983;55:361-364
    • (1983) Br. J. Anaesth. , vol.55 , pp. 361-364
    • Medak, R.1
  • 92
    • 0021366538 scopus 로고
    • Isoflurane anesthesia for a patient with long QT syndrome
    • Carlock FJ, Brown M, Brown EM. Isoflurane anesthesia for a patient with long QT syndrome. Can Anesth Soc J 1984;31:83-85
    • (1984) Can. Anesth. Soc. J. , vol.31 , pp. 83-85
    • Carlock, F.J.1    Brown, M.2    Brown, E.M.3
  • 93
    • 0032421152 scopus 로고    scopus 로고
    • Effects of sevoflurane on QT interval in a patient with congenital long QT syndrome
    • Gallagher JD, Weindling SN, Anderson G, Fillinger MP. Effects of sevoflurane on QT interval in a patient with congenital long QT syndrome. Anesthesiology 1998;89:1569-1573
    • (1998) Anesthesiology , vol.89 , pp. 1569-1573
    • Gallagher, J.D.1    Weindling, S.N.2    Anderson, G.3    Fillinger, M.P.4
  • 94
    • 0023216703 scopus 로고
    • Congenital long QT syndrome: Changes in QT interval during anesthesia with thiopental vecuronium fentanyl and isoflurane
    • Wilton NCT, Hantler CB. Congenital long QT syndrome: changes in QT interval during anesthesia with thiopental, vecuronium, fentanyl, and isoflurane. Anesth Analg 1987;66:357-360
    • (1987) Anesth. Analg. , vol.66 , pp. 357-360
    • Wilton, N.C.T.1    Hantler, C.B.2
  • 95
    • 36448991541 scopus 로고    scopus 로고
    • Treatment of alcohol and other drug dependence
    • Saitz R. Treatment of alcohol and other drug dependence. Liver Transpl 2007;13(11 Suppl 2):S59-64
    • (2007) Liver Transpl. , vol.13 , Issue.11
    • Saitz, R.1
  • 96
    • 0035212418 scopus 로고    scopus 로고
    • Enteral methadone to expedite fentanyl discontinuation and prevent opioid abstinence syndrome in the PICU
    • Lugo RA, MacLaren R, Cash J, et al. Enteral methadone to expedite fentanyl discontinuation and prevent opioid abstinence syndrome in the PICU. Pharmacotherapy 2001;21(12):1566-1573
    • (2001) Pharmacotherapy , vol.21 , Issue.12 , pp. 1566-1573
    • Lugo, R.A.1    MacLaren, R.2    Cash, J.3
  • 97
    • 65949096013 scopus 로고    scopus 로고
    • Drug-induced torsades de pointes: Data mining of the public version of the FDA Adverse event reporting systemAERS
    • Poluzzi E, Raschi E, Moretti U, De Ponti F. Drug-induced torsades de pointes: data mining of the public version of the FDA Adverse Event Reporting System(AERS). harmacoepidemiol Drug Saf 2009;18:512-518
    • (2009) Harmacoepidemiol Drug. Saf. , vol.18 , pp. 512-518
    • Poluzzi, E.1    Raschi, E.2    Moretti, U.3    De Ponti, F.4
  • 98
    • 38349081453 scopus 로고    scopus 로고
    • Physician awareness ofthe cardiac effects f methadone: Results of a national survey
    • Krantz MJ, Rowan SB, Schmitter J, Bucher Bartelson. Physician awareness ofthe cardiac effects f methadone: results of a national survey. J Addict Dis 2007;26(4):79-85
    • (2007) J. Addict. Dis. , vol.26 , Issue.4 , pp. 79-85
    • Krantz, M.J.1    Rowan, S.B.2    Schmitter, J.3    Bucher Bartelson4
  • 99
    • 62549083847 scopus 로고    scopus 로고
    • QTc interval screening in methadone treatment
    • Krantz MJ, Martin J, Stimmel B, et al. QTc interval screening in methadone treatment. Ann Intern Med 2009;150:387-395
    • (2009) Ann. Intern. Med. , vol.150 , pp. 387-395
    • Krantz, M.J.1    Martin, J.2    Stimmel, B.3
  • 101
    • 0037674750 scopus 로고    scopus 로고
    • Dose-related effects of methadone on QT prolongation in a series of patients with torsades de pointes
    • Krantz MJ, Kutinsky IB, Robertson AD, Mehler PS. Dose-related effects of methadone on QT prolongation in a series of patients with torsades de pointes. Pharmacotherapy 2003;23(6):802-805
    • (2003) Pharmacotherapy , vol.23 , Issue.6 , pp. 802-805
    • Krantz, M.J.1    Kutinsky, I.B.2    Robertson, A.D.3    Mehler, P.S.4
  • 103
    • 0034891470 scopus 로고    scopus 로고
    • Delirium in an intensive care unit: A study of risk factors
    • Dubois MJ, Bergeron N, Dumont M, et al. Delirium in an intensive care unit: a study of risk factors. Intensive Care Med 2001;27:1297-1304
    • (2001) Intensive Care Med. , vol.27 , pp. 1297-1304
    • Dubois, M.J.1    Bergeron, N.2    Dumont, M.3
  • 104
    • 0036738393 scopus 로고    scopus 로고
    • Managing delirium in the intensive care unit
    • Dial S, Payne J. Managing delirium in the intensive care unit. Clin Pulm Med 2002;9:260-266
    • (2002) Clin. Pulm. Med. , vol.9 , pp. 260-266
    • Dial, S.1    Payne, J.2
  • 105
    • 0032951356 scopus 로고    scopus 로고
    • Practice guideline for the treatment of patients with delirium
    • American Psychiatric Association.
    • American Psychiatric Association. Practice guideline for the treatment of patients with delirium. Am J Psychiatry 1999;156:1-20
    • (1999) Am. J. Psychiatry , vol.156 , pp. 1-20
  • 106
    • 0036097548 scopus 로고    scopus 로고
    • The delirium experience: Delirium recall and delirium-related distress in hospitalized patients with cancer-their spouses/caregivers, and their nurses
    • Breitbart W, Gibson C, Tremblay A. The delirium experience: delirium recall and delirium-related distress in hospitalized patients with cancer-their spouses/caregivers, and their nurses. Psychosomatics 2002;43:183-194
    • (2002) Psychosomatics , vol.43 , pp. 183-194
    • Breitbart, W.1    Gibson, C.2    Tremblay, A.3
  • 107
    • 0021238204 scopus 로고
    • Psychotropic drugs and alcohol: Pharmacokinetic and pharmacodynamic interactions
    • Weller R, Preskorn SH. Psychotropic drugs and alcohol: pharmacokinetic and pharmacodynamic interactions. Psychosomatics 1984;25:301-309
    • (1984) Psychosomatics , vol.25 , pp. 301-309
    • Weller, R.1    Preskorn, S.H.2
  • 108
    • 0032915073 scopus 로고    scopus 로고
    • Long-term treatment with antipsychotic drugs in conventional doses prolonged QTc dispersion but did not increase ventricular tachyarrhythmias in patients with schizophrenia in the absence of cardiac disease
    • Kitayama H, Kiuchi K, Nejima J, et al. Long-term treatment with antipsychotic drugs in conventional doses prolonged QTc dispersion, but did not increase ventricular tachyarrhythmias in patients with schizophrenia in the absence of cardiac disease. Eur J Clin Pharmacol 1999;55(4):259-262
    • (1999) Eur. J. Clin. Pharmacol. , vol.55 , Issue.4 , pp. 259-262
    • Kitayama, H.1    Kiuchi, K.2    Nejima, J.3
  • 109
    • 0034712552 scopus 로고    scopus 로고
    • QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients
    • Reilly JG, Ayis SA, Ferrier IN, et al. QTc-interval abnormalities and psychotropic drug therapy in psychiatric patients. Lancet 2000;355(9209):1048- 1052
    • (2000) Lancet , vol.355 , Issue.9209 , pp. 1048-1052
    • Reilly, J.G.1    Ayis, S.A.2    Ferrier, I.N.3
  • 110
    • 0029922080 scopus 로고    scopus 로고
    • Electrocardiographic changes in patients receiving neuroleptic medication
    • Warner JP, Barnes TR, Henry JA. Electrocardiographic changes in patients receiving neuroleptic medication. Acta Psychiatr Scand 1996;93(4):311-313
    • (1996) Acta. Psychiatr Scand. , vol.93 , Issue.4 , pp. 311-313
    • Warner, J.P.1    Barnes, T.R.2    Henry, J.A.3
  • 111
  • 112
    • 0032518968 scopus 로고    scopus 로고
    • Torsades de pointed associated with intravenous haloperidol in critically ill patients
    • Sharma ND, Rosman HS, Padhi ID, et al. Torsades de pointed associated with intravenous haloperidol in critically ill patients. Am J Cardiol 1998;81:238-240
    • (1998) Am. J. Cardiol. , vol.81 , pp. 238-240
    • Sharma, N.D.1    Rosman, H.S.2    Padhi, I.D.3
  • 113
    • 6344228571 scopus 로고    scopus 로고
    • Antipsychotic-induced QTc interval prolongation
    • Dewan V, Roth BA. Antipsychotic-induced QTc interval prolongation. Can J Psychiatry 2004;49:646
    • (2004) Can. J. Psychiatry , vol.49 , pp. 646
    • Dewan, V.1    Roth, B.A.2
  • 114
    • 0037594766 scopus 로고    scopus 로고
    • QTc prolongation: Chlorpromazine and high dose olanzapine
    • Gurovich I, Vempaty A, Lippman S. QTc prolongation: chlorpromazine and high dose olanzapine. Can J Psychiatry 2003;48:348
    • (2003) Can. J. Psychiatry , vol.48 , pp. 348
    • Gurovich, I.1    Vempaty, A.2    Lippman, S.3
  • 115
  • 116
    • 77955940370 scopus 로고    scopus 로고
    • QTc prolongation: Possible association with risperidone and/or haloperidol
    • Nandagopal JJ, Craig JM, Lippmann S. QTc prolongation: possible association with risperidone and/or haloperidol. Psychosomatics 2000;41:63-65
    • (2000) Psychosomatics , vol.41 , pp. 63-65
    • Nandagopal, J.J.1    Craig, J.M.2    Lippmann, S.3
  • 117
    • 70349165363 scopus 로고    scopus 로고
    • Long QT syndrome and torsades de pointes induced by acute sulpiride poisoning
    • Chang JH, Weng TI, Fang CC. Long QT syndrome and torsades de pointes induced by acute sulpiride poisoning. Am J Emerg Med 2009;27(8):1016
    • (2009) Am. J. Emerg. Med. , vol.27 , Issue.8 , pp. 1016
    • Chang, J.H.1    Weng, T.I.2    Fang, C.C.3
  • 119
    • 34247597884 scopus 로고    scopus 로고
    • Sulpiride induced torsade de pointes
    • Huang BH, Hsia CP, Chen CY. Sulpiride induced torsade de pointes. Int J Cardiol 2007;118(3):100-102
    • (2007) Int. J. Cardiol. , vol.118 , Issue.3 , pp. 100-102
    • Huang, B.H.1    Hsia, C.P.2    Chen, C.Y.3
  • 120
    • 0034077924 scopus 로고    scopus 로고
    • Effects of nortriptyline and paroxetine on QT variability in patients with panic disorder
    • Yeragani VK, Pohl R, Jampala VC, et al. Effects of nortriptyline and paroxetine on QT variability in patients with panic disorder. Depress Anxiety 2000;11:126-130
    • (2000) Depress Anxiety. , vol.11 , pp. 126-130
    • Yeragani, V.K.1    Pohl, R.2    Jampala, V.C.3
  • 121
    • 0024158956 scopus 로고
    • InvestigatorsEffects of encainide, flecainide, imipramine, and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: The CAPS
    • The Cardiac Arrhythmia Pilot Study (CAPS)
    • The Cardiac Arrhythmia Pilot Study (CAPS) InvestigatorsEffects of encainide, flecainide, imipramine, and moricizine on ventricular arrhythmias during the year after acute myocardial infarction: the CAPS. Am J Cardiol 1988;61:501-509
    • (1988) Am. J. Cardiol. , vol.61 , pp. 501-509
  • 122
    • 0031567882 scopus 로고    scopus 로고
    • Abnormal ventricular repolarization mimicking myocardial infarction after heterocyclic antidepressant overdose
    • Bolognesi R, Tsialtas D, Vasini P, et al. Abnormal ventricular repolarization mimicking myocardial infarction after heterocyclic antidepressant overdose. Am J Cardiol 1997;79:242-243
    • (1997) Am. J. Cardiol. , vol.79 , pp. 242-243
    • Bolognesi, R.1    Tsialtas, D.2    Vasini, P.3
  • 123
    • 0033033419 scopus 로고    scopus 로고
    • Speculations on difference between tricyclic and selective serotonin reuptake inhibitor and antidepressants on their cardiac effects Is there any
    • Pacher P, Ungvari Z, Nanasi PP, et al. Speculations on difference between tricyclic and selective serotonin reuptake inhibitor and antidepressants on their cardiac effects. Is there any? Curr Med Chem 1999;6:469-480
    • (1999) Curr. Med. Chem. , vol.6 , pp. 469-480
    • Pacher, P.1    Ungvari, Z.2    Nanasi, P.P.3
  • 124
    • 33750480200 scopus 로고    scopus 로고
    • Drug-induced long QT syndrome: hERG K+ channel block and disruption of protein trafficking by fluoxetine and norfluoxetine
    • Rajamani S, Eckhardt LL, Klemens CA, et al. Drug-induced long QT syndrome: hERG K+ channel block and disruption of protein trafficking by fluoxetine and norfluoxetine. Br J Pharmacol 2006;149:481-489
    • (2006) Br. J. Pharmacol. , vol.149 , pp. 481-489
    • Rajamani, S.1    Eckhardt, L.L.2    Klemens, C.A.3
  • 125
    • 0037070199 scopus 로고    scopus 로고
    • Inhibitory actions of the selective serotonin re-uptake inhibitor citalopram on HERG and ventricular L-type calcium currents
    • Witchel HJ, Pabbathi VK, Hofmann G, et al. Inhibitory actions of the selective serotonin re-uptake inhibitor citalopram on HERG and ventricular L-type calcium currents. FEBS Lett 2002;512:59-66
    • (2002) FEBS Lett. , vol.512 , pp. 59-66
    • Witchel, H.J.1    Pabbathi, V.K.2    Hofmann, G.3
  • 126
    • 33645014063 scopus 로고    scopus 로고
    • QTc prolongation and torsades de pointes in an elderly woman taking fluoxetine
    • Wilting I, Smals OM, Holwerda NJ, et al. QTc prolongation and torsades de pointes in an elderly woman taking fluoxetine. Am J Psychiatry 2006;163:325
    • (2006) Am. J. Psychiatry , vol.163 , pp. 325
    • Wilting, I.1    Smals, O.M.2    Holwerda, N.J.3
  • 127
    • 0035952264 scopus 로고    scopus 로고
    • Fluoxetine Prozac as a cause of QT prolongation
    • Varriale P. Fluoxetine (Prozac) as a cause of QT prolongation. Arch Intern Med 2001;161:612
    • (2001) Arch. Intern. Med. , vol.161 , pp. 612
    • Varriale, P.1
  • 128
    • 56349148945 scopus 로고    scopus 로고
    • Citalopram induced torsades de pointes a rare life threatening side effect
    • Kanjanauthai S, Kanluen T, Chareonthaitawee P. Citalopram induced torsades de pointes, a rare life threatening side effect. Int J Cardiol 2008;131(1):e33-4
    • (2008) Int. J. Cardiol. , vol.131 , Issue.1
    • Kanjanauthai, S.1    Kanluen, T.2    Chareonthaitawee, P.3
  • 130
    • 0442323094 scopus 로고    scopus 로고
    • Pharmacokinetic factors in the adverse cardiovascular effects of antipsychotic drugs
    • Brown CS, Farmer RG, Soberman JE, et al. Pharmacokinetic factors in the adverse cardiovascular effects of antipsychotic drugs. Clin Pharmacokinet 2004;43:33-56
    • (2004) Clin. Pharmacokinet. , vol.43 , pp. 33-56
    • Brown, C.S.1    Farmer, R.G.2    Soberman, J.E.3
  • 131
    • 4444254932 scopus 로고    scopus 로고
    • Drugs and the QT interval-caveat doctor
    • Liu BA, Juurlink DN. Drugs and the QT interval-caveat doctor. N Engl J Med 2004;351:1053-1056
    • (2004) N. Engl. J. Med. , vol.351 , pp. 1053-1056
    • Liu, B.A.1    Juurlink, D.N.2
  • 132
    • 0019801672 scopus 로고
    • Interaction of chlorpromazine and nortriptyline inpatients with chizophrenia
    • Loga S, Curry S, Lader M. Interaction of chlorpromazine and nortriptyline inpatients with chizophrenia. Clin Pharmacokinet 1981;6:454-462
    • (1981) Clin Pharmacokinet. , vol.6 , pp. 454-462
    • Loga, S.1    Curry, S.2    Lader, M.3
  • 133
    • 45849103106 scopus 로고    scopus 로고
    • Proarrhythmic potential of antimicrobial agents
    • Simko J, Csilek A, Karaszi J, Lorincz I. Proarrhythmic potential of antimicrobial agents. Infection 2008;36:194-206
    • (2008) Infection. , vol.36 , pp. 194-206
    • Simko, J.1    Csilek, A.2    Karaszi, J.3    Lorincz, I.4
  • 134
    • 0037100316 scopus 로고    scopus 로고
    • Concomitant risk factors in reports of torsades de pointes associated with macrolide use: Review of the United States Food and Drug Administration Adverse Event Reporting System
    • Schaffer D, Singer S, Korvick J, Honig P. Concomitant risk factors in reports of torsades de pointes associated with macrolide use: review of the United States Food and Drug Administration Adverse Event Reporting System. Clin Infect Dis 2002;35:197-200
    • (2002) Clin. Infect. Dis. , vol.35 , pp. 197-200
    • Schaffer, D.1    Singer, S.2    Korvick, J.3    Honig, P.4
  • 135
    • 0034801580 scopus 로고    scopus 로고
    • Clinical aspects of ventricular arrhythmias associated with QT prolongation
    • Haverkamp W, Eckardt L, Monnlg G, et al. Clinical aspects of ventricular arrhythmias associated with QT prolongation. Eur Heart J Suppl 2001;3 (Suppl K):K81-8
    • (2001) Eur. Heart J. Suppl. , vol.3 , Issue.K
    • Haverkamp, W.1    Eckardt, L.2    Monnlg, G.3
  • 136
    • 0035293881 scopus 로고    scopus 로고
    • Risk assessment for antimicrobial agent-induced QTc interval prolongation and torsades de pointes
    • Owens RC Jr. Risk assessment for antimicrobial agent-induced QTc interval prolongation and torsades de pointes. Pharmacotherapy 2001;21(3):301-319
    • (2001) Pharmacotherapy , vol.21 , Issue.3 , pp. 301-319
    • Owens, R.C.1
  • 137
    • 0030773405 scopus 로고    scopus 로고
    • A review of erythromycin-induced malignant tachyarrythmia-torsades de pointes a case report
    • Katapadi K, Kostandy G, Katapadi M, et al. A review of erythromycin-induced malignant tachyarrythmia-torsades de pointes. A case report. Angiology 1997;48:821-826
    • (1997) Angiology , vol.48 , pp. 821-826
    • Katapadi, K.1    Kostandy, G.2    Katapadi, M.3
  • 139
    • 0035170062 scopus 로고    scopus 로고
    • Interactions of a series of fluoroquinolone antibacterial drugs with the human cardia K+ channel HERG
    • Kang J, Wang L, Chen XL, et al. Interactions of a series of fluoroquinolone antibacterial drugs with the human cardia K+ channel HERG. Mol Pharmacol 2001;59:122-126
    • (2001) Mol. Pharmacol. , vol.59 , pp. 122-126
    • Kang, J.1    Wang, L.2    Chen, X.L.3
  • 140
    • 0036235148 scopus 로고    scopus 로고
    • Torsdaes de pointed associated with ciprofloxacin ofloxacin levofloxacin gatifloxacin and moxifloxacin
    • Owens RCJ, Ambrose PG. Torsdaes de pointed associated with ciprofloxacin, ofloxacin levofloxacin, gatifloxacin, and moxifloxacin. Pharmacotherapy 2002;22(5):663-672
    • (2002) Pharmacotherapy , vol.22 , Issue.5 , pp. 663-672
    • Owens, R.C.J.1    Ambrose, P.G.2
  • 141
    • 33845484566 scopus 로고    scopus 로고
    • Ciprofloxacin associated with a much lower rate of torsades de pointes than levofloxacin gatifloxacin or moxifloxacin in the FDA spontaneous reporting database abstract L-589
    • Washington DC American Society for Microbiology Washington DC
    • Frothingham R. Ciprofloxacin associated with a much lower rate of torsades de pointes than levofloxacin, gatifloxacin, or moxifloxacin in the FDA spontaneous reporting database [abstract L-589]. In: Program and abstracts of the 45th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (Washington DC). American Society for Microbiology, Washington, DC; 2005. p. 392
    • (2005) Program and abstracts of the 45th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy , pp. 392
    • Frothingham, R.1
  • 143
    • 33645399023 scopus 로고    scopus 로고
    • Outpatient gatifloxacin therapy and dysglycemia in older adults
    • Park-Wyllie LY, Juurlink DN, Kopp A, Shah BR. Outpatient gatifloxacin therapy and dysglycemia in older adults. N Eng J Med 2006;354 (13):1352-1361
    • (2006) N. Eng. J. Med. , vol.354 , Issue.13 , pp. 1352-1361
    • Park-Wyllie, L.Y.1    Juurlink, D.N.2    Kopp, A.3    Shah, B.R.4
  • 145
    • 27744540341 scopus 로고    scopus 로고
    • QT prolongation and proarrhythmia by moxifloxacin:concordance of preclinical models in realtion to clinical outcome
    • Chen X, Cass JD, Bradley JA, et al. QT prolongation and proarrhythmia by moxifloxacin:concordance of preclinical models in realtion to clinical outcome. Br J Pharmcacol 2005;146:792-799
    • (2005) Br. J. Pharmcacol. , vol.146 , pp. 792-799
    • Chen, X.1    Cass, J.D.2    Bradley, J.A.3
  • 146
    • 2942560844 scopus 로고    scopus 로고
    • QT prolongation with antimicrobial agents
    • Owens RC. QT prolongation with antimicrobial agents. Drugs 2004;64(10):1091-1124
    • (2004) Drugs , vol.64 , Issue.10 , pp. 1091-1124
    • Owens, R.C.1
  • 147
    • 0031939246 scopus 로고    scopus 로고
    • Systemic antifungal agents drug interactions of clinical significance
    • Albengres E, Le Louet H, Tillement JP. Systemic antifungal agents. Drug interactions of clinical significance. Drug Saf 1998;18:83-97
    • (1998) Drug. Saf. , vol.18 , pp. 83-97
    • Albengres, E.1    Le Louet, H.2    Tillement, J.P.3
  • 148
    • 0037205542 scopus 로고    scopus 로고
    • Voriconazole-better chances for patients with invasive mycoses
    • Ghannoum MA, Kuhn DM. Voriconazole-better chances for patients with invasive mycoses. Eur J Med Res 2002;7(5):242-256
    • (2002) Eur. J. Med. Res. , vol.7 , Issue.5 , pp. 242-256
    • Ghannoum, M.A.1    Kuhn, D.M.2
  • 149
    • 0027231225 scopus 로고
    • The effect of fluconazole on the steady-state pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine in humans
    • Honig PK, Worham DC, Zamani K, et al. The effect of fluconazole on the steady-state pharmacokinetics and electrocardiographic pharmacodynamics of terfenadine in humans. Clin Pharmacol Ther 1993;53:630-636
    • (1993) Clin. Pharmacol. Ther. , vol.53 , pp. 630-636
    • Honig, P.K.1    Worham, D.C.2    Zamani, K.3
  • 150
    • 33745943868 scopus 로고    scopus 로고
    • Quetiapine in overdosage:A clinical and pharmacokinetic analysis of 14 cases
    • Hunfeld NG, Westerman EM, Boswijk DJ, et al. Quetiapine in overdosage:a clinical and pharmacokinetic analysis of 14 cases. Ther Drug Monit 2006;28(2):185-189
    • (2006) Ther. Drug. Monit. , vol.28 , Issue.2 , pp. 185-189
    • Hunfeld, N.G.1    Westerman, E.M.2    Boswijk, D.J.3
  • 151
    • 67651216047 scopus 로고    scopus 로고
    • Quetiapine overdose: predicting intubation, duration of ventilation, cardiac monitoring and the effect of activated charcoal
    • Isbister GK, Duffull SB. Quetiapine overdose: predicting intubation, duration of ventilation, cardiac monitoring and the effect of activated charcoal. Int Clin Psychopharmacol 2009;24:174-180
    • (2009) Int Clin Psychopharmacol , vol.24 , pp. 174-180
    • Isbister, G.K.1    Duffull, S.B.2
  • 152
    • 54149106854 scopus 로고    scopus 로고
    • Acute quetiapine overdose in adults: A 5-year retrospective case series
    • Ngo A, Ciranni M, Olson KR. Acute quetiapine overdose in adults: A 5-year retrospective case series. Ann Emerg Med 2008;52:541-547
    • (2008) Ann. Emerg. Med. , vol.52 , pp. 541-547
    • Ngo, A.1    Ciranni, M.2    Olson, K.R.3
  • 153
    • 0032705044 scopus 로고    scopus 로고
    • Acute quetiapine poisoning
    • Hustey FM. Acute quetiapine poisoning. J Emerg Med 1999;17:995-997
    • (1999) J. Emerg. Med. , vol.17 , pp. 995-997
    • Hustey, F.M.1
  • 156
    • 0025976827 scopus 로고
    • Life threatening ventricular arrhythmia torsades de pointes after haloperidol overdose
    • Henderson RA, Lane S, Henry JA. Life threatening ventricular arrhythmia (torsades de pointes) after haloperidol overdose. Hum Exp Toxicol 1991;10(1):59-62
    • (1991) Hum. Exp. Toxicol. , vol.10 , Issue.1 , pp. 59-62
    • Henderson, R.A.1    Lane, S.2    Henry, J.A.3
  • 157
    • 4444284449 scopus 로고    scopus 로고
    • Relative toxicity of selective serotonin reuptake inhibitors SSRIs in overdose
    • Isbister GK, Bowe SJ, Dawson A, et al. Relative toxicity of selective serotonin reuptake inhibitors (SSRIs) in overdose. J Toxicol Clin Toxicol 2004;42:277-285
    • (2004) J. Toxicol. Clin. Toxicol. , vol.42 , pp. 277-285
    • Isbister, G.K.1    Bowe, S.J.2    Dawson, A.3
  • 158
    • 1842367966 scopus 로고    scopus 로고
    • Citalopram overdose: Review of cases treated in Swedish hospitals
    • Personne M, Sjoberg G, Persson H. Citalopram overdose: review of cases treated in Swedish hospitals. J Toxicol Clin Toxicol 1997;35:237-240
    • (1997) J. Toxicol. Clin Toxicol. , vol.35 , pp. 237-240
    • Personne, M.1    Sjoberg, G.2    Persson, H.3
  • 159
    • 35349011020 scopus 로고    scopus 로고
    • Activated charcoal decreases the risk of QT prolongation after citalopram overdose
    • Isbister GK, Friberg LE, Stokes B, et al. Activated charcoal decreases the risk of QT prolongation after citalopram overdose. Ann Emerg Med 2007;50:593-600
    • (2007) Ann. Emerg. Med. , vol.50 , pp. 593-600
    • Isbister, G.K.1    Friberg, L.E.2    Stokes, B.3
  • 160
    • 58149204333 scopus 로고    scopus 로고
    • Prolonged QTc interval in a 14-year-old girl with escitalopram overdose
    • Scharko AM, Schumacher J. Prolonged QTc interval in a 14-year-old girl with escitalopram overdose. J Child Adolescent Psychopharmacology 2008;18(3):297-298
    • (2008) J. Child. Adolescent Psychopharmacology , vol.18 , Issue.3 , pp. 297-298
    • Scharko, A.M.1    Schumacher, J.2
  • 162
    • 34447303115 scopus 로고    scopus 로고
    • Cardiovascular toxicity due to venlafaxine poisoning in adults: A review of 235 consecutive cases
    • Howell C, Wilson AD, Waring WS. Cardiovascular toxicity due to venlafaxine poisoning in adults: a review of 235 consecutive cases. Br J Clin Pharmacol 2007;64(2):192-197
    • (2007) Br. J. Clin. Pharmacol. , vol.64 , Issue.2 , pp. 192-197
    • Howell, C.1    Wilson, A.D.2    Waring, W.S.3
  • 163
    • 65349165746 scopus 로고    scopus 로고
    • Electrocardiogram changes and arrythmias in venlafaxine overdose
    • Isbister GK. Electrocardiogram changes and arrythmias in venlafaxine overdose. Br J Clin Pharmacol 2009;67(5):572-576
    • (2009) Br. J. Clin. Pharmacol. , vol.67 , Issue.5 , pp. 572-576
    • Isbister, G.K.1
  • 164
    • 0025233676 scopus 로고
    • Adverse cardiac effects of combined neuroleptic ingestion and tricyclic antidepressant overdose
    • Wilens TE, Stern TA, OGara PT. Adverse cardiac effects of combined neuroleptic ingestion and tricyclic antidepressant overdose. J Clin Psychopharmacol 1990;10(1):51-54
    • (1990) J. Clin. Psychopharmacol. , vol.10 , Issue.1 , pp. 51-54
    • Wilens, T.E.1    Stern, T.A.2    Ogara, P.T.3
  • 165
    • 33748642599 scopus 로고    scopus 로고
    • ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/ American Heart Association Task Force and the European Society
    • European Heart Rhythm Association, Heart Rhythm Society.
    • Zipes DP, Camm AJ, Borggrefe M, et al.; European Heart Rhythm Association, Heart Rhythm Society. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/ American Heart Association Task Force and the European Society. J Am Coll Cardiol 2006;48(5):e247-346
    • (2006) J. Am. Coll. Cardiol. , vol.48 , Issue.5
    • Zipes, D.P.1    Camm, A.J.2    Borggrefe, M.3
  • 166
    • 0023870752 scopus 로고
    • Treatment of torsades de pointes with magnesium sulfate
    • Tzivoni D, Banai S, Schuger C, et al. Treatment of torsades de pointes with magnesium sulfate. Circulation 1988;77:392-397
    • (1988) Circulation. , vol.77 , pp. 392-397
    • Tzivoni, D.1    Banai, S.2    Schuger, C.3
  • 167
    • 34249330240 scopus 로고    scopus 로고
    • Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes
    • Gupta A, Lawrence AT, Krishnan K, et al. Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes. Am Heart J 2007;153:891-899
    • (2007) Am. Heart J. , vol.153 , pp. 891-899
    • Gupta, A.1    Lawrence, A.T.2    Krishnan, K.3
  • 168
    • 0018843329 scopus 로고
    • Permanent overdrive pacing for the suppression of recurrent ventricular tachycardia in a newborn with long QT syndrome
    • Di Segni E, David D, Katzenstein M, et al. Permanent overdrive pacing for the suppression of recurrent ventricular tachycardia in a newborn with long QT syndrome. J Electrocardiol 1980;13:189-192
    • (1980) J. Electrocardiol. , vol.13 , pp. 189-192
    • Di Segni, E.1    David, D.2    Katzenstein, M.3
  • 169
    • 0036155193 scopus 로고    scopus 로고
    • Clinical and therapeutic aspects of congenital and acquired long QT syndrome
    • Khan IA. Clinical and therapeutic aspects of congenital and acquired long QT syndrome. Am J Med 2002;112:58-66
    • (2002) Am. J. Med. , vol.112 , pp. 58-66
    • Khan, I.A.1
  • 172
    • 0035830365 scopus 로고    scopus 로고
    • Genotype-phenotype correlation in the long-QT syndrome: Gene-specific triggers for life-threatening arrhythmias
    • Schwartz, PJ, Priori SG, Spazzolini C, et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 2001;103:89-95
    • (2001) Circulation , vol.103 , pp. 89-95
    • Schwartz, P.J.1    Priori, S.G.2    Spazzolini, C.3
  • 173
    • 43049131057 scopus 로고    scopus 로고
    • Pharmacologic approach to the treatment of long and short QT syndromes
    • Patel C, Antzelevitch C. Pharmacologic approach to the treatment of long and short QT syndromes. Pharm Ther 2008;118:138-151
    • (2008) Pharm. Ther. , vol.118 , pp. 138-151
    • Patel, C.1    Antzelevitch, C.2
  • 174
    • 0037623309 scopus 로고    scopus 로고
    • Implantable cardioverter defibrillator in high-risk long QT syndrome patients
    • Zareba W, Moss AJ, Daubert JP, et al. Implantable cardioverter defibrillator in high-risk long QT syndrome patients. J Cardiovasc Electrophysiol 2003;14:337-341
    • (2003) J. Cardiovasc Electrophysiol. , vol.14 , pp. 337-341
    • Zareba, W.1    Moss, A.J.2    Daubert, J.P.3
  • 175
    • 33947528431 scopus 로고    scopus 로고
    • Role of implantable cardioverter defibrillator therapy in patients with long QT syndrome
    • Daubert JP, Zareba W, Rosero SZ, et al. Role of implantable cardioverter defibrillator therapy in patients with long QT syndrome. Am J Heart 2007;153:S53-8
    • (2007) Am. J. Heart. , vol.153
    • Daubert, J.P.1    Zareba, W.2    Rosero, S.Z.3
  • 176
    • 0036855270 scopus 로고    scopus 로고
    • What is the minimal pacing rate that prevents torsades de pointes Insights from patients with permanent pacemakers
    • Pinski SL, Eguia LE, Trohman RG. What is the minimal pacing rate that prevents torsades de pointes? Insights from patients with permanent pacemakers. Pacing Clin Electrophysiol 2002;25:1612-1615
    • (2002) Pacing Clin Electrophysiol. , vol.25 , pp. 1612-1615
    • Pinski, S.L.1    Eguia, L.E.2    Trohman, R.G.3
  • 177
    • 7644243300 scopus 로고    scopus 로고
    • Cardiac pacing: The state of the art
    • Trohman RG, Kim MH, Pinski SL. Cardiac pacing: the state of the art. Lancet 2004;364:1701-1719
    • (2004) Lancet , vol.364 , pp. 1701-1719
    • Trohman, R.G.1    Kim, M.H.2    Pinski, S.L.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.